274
Views
18
CrossRef citations to date
0
Altmetric
Review

Safety, efficacy and patient satisfaction with continuous daily administration of levonorgestrel/ethinylestradiol oral contraceptives

, &
Pages 131-143 | Published online: 29 Apr 2009

Figures & data

Figure 1 Norgestrel: 8R,9S,10R,13S,14S,17S-13-ethyl-17-ethynyl-17-hydroxy- 1, 2, 6, 7, 8, 9, 10, 11, 12, 14, 15, 16-dodecahydrocyclopenta[a]phenanthren-3-one.

Figure 1 Norgestrel: 8R,9S,10R,13S,14S,17S-13-ethyl-17-ethynyl-17-hydroxy- 1, 2, 6, 7, 8, 9, 10, 11, 12, 14, 15, 16-dodecahydrocyclopenta[a]phenanthren-3-one.

Figure 2 The “Progestogen Tree.”

Courtesy Prof. A Genazzani, University of Pisa, Italy.

Abbreviations: CMA, chlormadinone acetate; CPA, cyproterone acetate; DNG, dienogest; DRSP, drospirenone; DSG, desogestrol; GST, gestodenes; MGA, megestrol acetate; LNG, levonorgestrol; MPA, medroxyprogesterone acetate; NETA; norethindrone acetate; TMG, trimegestone
Figure 2 The “Progestogen Tree.”Courtesy Prof. A Genazzani, University of Pisa, Italy.

Table 1 Biological activity of different progestogens, using two different tests

Table 2 Hormonal contraceptives containing norgestrel or levonorgestrel

Figure 3 Percentage of subjects reporting no bleeding in each treatment cycle. Asterisks indicate significant difference (p = 0.05) within a cycle.

Reproduced with permission from Kwiecien M, Edelman A, Nichols MD, Jensen JF. Bleeding patterns and patient acceptability of standard or continuous dosing regimens of a low-dose oral contraceptive: a randomized trial. Contraception. 2003;67:9–13.Citation83 Copyright © 2003 Elsevier.

Figure 3 Percentage of subjects reporting no bleeding in each treatment cycle. Asterisks indicate significant difference (p = 0.05) within a cycle.Reproduced with permission from Kwiecien M, Edelman A, Nichols MD, Jensen JF. Bleeding patterns and patient acceptability of standard or continuous dosing regimens of a low-dose oral contraceptive: a randomized trial. Contraception. 2003;67:9–13.Citation83 Copyright © 2003 Elsevier.